関連する実験動画
Updated: Sep 10, 2025
06:01
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
15.0K
鈍い脳血管損傷に関連した不血性脳卒中における高血栓性の役割
Dayna M Carlson1, Matthew K Mcintyre2, Joseph Nugent2
1School of Medicine, Oregon Health and Science University, United States.
まとめ
高血栓性脳血管損傷 (BCVI) 患者では,脳卒中のリスクが増加しました. トロンボエラストグラフィー (TEG) と凝固研究により,早期の抗血栓予防のために高リスクの個人を特定することができます.
科学分野:
- 神経科学
- トラウマ 手術
- 血液学
背景:
- 鈍い脳血管損傷 (BCVI) は,壊滅的な脳卒中につながる可能性があります.
- 凝固状態の評価は,抗血栓療法におけるリスクの階層化を改善する可能性があります.
- 高血栓状態は,BCVI後の不血性脳卒中の発生に影響を与える可能性があります.
研究 の 目的:
- 血栓性状態がBCVI後に発症する不全性脳卒中の影響を評価する.
- トロンボエラストグラフィ (TEG) を含む凝固プロファイルの有用性を評価する.
主な方法:
- 2010年から2023年の間に入院したBCVI患者の遡及研究.
- 入院後24時間以内にTEGを受けた患者も含む.
- 主要アウトカム:BCVIの分布における不血性脳卒中;ROC分析を使用した.
主要な成果:
- 38人の患者のうち7人 (18. 4%) が不血性脳卒中を患った.
- 脳卒中グループは,R値,フィブリノゲン,aPTTの低下を示した.
- R値,フィブリノゲン,PTTは,脳卒中に対する高い差別値を示した (AUC 0. 75- 0. 76).
結論:
- 高血圧は,BCVIに関連した不全性脳卒中の発生率の増加と関連しています.
- TEGと凝固試験により,高リスクの患者を特定できます.
- 早期に抗血栓予防療法を開始することは,リスクのある患者にとって有益である.
さらに関連する動画
関連する概念動画
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
01:05Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:09Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
01:16Clot Retraction and Fibrinolysis
6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K